Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

ClinicalTrials.gov ID: NCT01660633

Public ClinicalTrials.gov record NCT01660633. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

Study identification

NCT ID
NCT01660633
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Acrotech Biopharma Inc.
Industry
Enrollment
61 participants

Conditions and interventions

Interventions

  • High-Dose Melphalan HCL for Injection (Propylene Glycol-Free) Drug
  • Autologous Transplantation Other

Drug · Other

Eligibility (public fields only)

Age range
Up to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2012
Primary completion
Jan 31, 2014
Completion
Jul 31, 2014
Last update posted
Apr 20, 2020

2012 – 2014

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
Rush University Medical Center Chicago Illinois 60612
University of Kansas Medical Center Fairway Kansas 66205
University of Massachusetts Worcester Massachusetts 01655
Washington University School of Medicine St Louis Missouri 63110
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792
Medical College of Wisconsin/Froedtert Hospital Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01660633, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2020 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01660633 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →